Ozempic competitor to launch in spite of PBS knockback

Eli Lilly’s Mounjaro will be on the private scrip market by the end of September Revolutionary new type 2 diabetes drug Mounjaro – which is almost better known for producing spectacular weight-loss results – will be launched in Australia later in September despite it not being added to the Pharmaceutical Benefits Scheme (PBS). The announcement